APA引用形式

Zhang, H., Hylander, B. L., LeVea, C., Repasky, E. A., Straubinger, R. M., Adjei, A. A., & Ma, W. W. (2014). Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models. Nature Publishing Group.

シカゴスタイル引用形

Zhang, H., B L. Hylander, C. LeVea, E A. Repasky, R M. Straubinger, A A. Adjei, , W W. Ma. Enhanced FGFR Signalling Predisposes Pancreatic Cancer to the Effect of a Potent FGFR Inhibitor in Preclinical Models. Nature Publishing Group, 2014.

MLA引用形式

Zhang, H., et al. Enhanced FGFR Signalling Predisposes Pancreatic Cancer to the Effect of a Potent FGFR Inhibitor in Preclinical Models. Nature Publishing Group, 2014.